Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
29.1M
-
Shares change
-
+686K
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$27.4M
-
Put/Call ratio
-
16.43
-
Number of buys
-
117
-
Number of sells
-
-76
-
Price
-
$35.90
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2022
225 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2022.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 50.5M outstanding shares and own 57.72% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.1M shares), FEDERATED HERMES, INC. (3.49M shares), VANGUARD GROUP INC (2.48M shares), DIMENSIONAL FUND ADVISORS LP (1.8M shares), STATE STREET CORP (1.32M shares), Invesco Ltd. (734K shares), GEODE CAPITAL MANAGEMENT, LLC (703K shares), FULLER & THALER ASSET MANAGEMENT, INC. (615K shares), Nuveen Asset Management, LLC (477K shares), and Assenagon Asset Management S.A. (428K shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.